SOW
EWTX icon

State of Wyoming’s Edgewise Therapeutics EWTX Stock Holding History

State of Wyoming’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Buy
+12,913
New +$445K 0.05% 376
2022
Q2 		– Sell
-33
Closed – – 1947
2022
Q1 		$0 Buy
33
+6
+22% +$77 ﹤0.01% 1861
2021
Q4 		$0 Sell
27
-2
-7% -$36 ﹤0.01% 1897
2021
Q3 		$0 Sell
29
-13
-31% -$235 ﹤0.01% 1247
2021
Q2 		$1K Buy
+42
New +$1.15K ﹤0.01% 1131

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State of Wyoming's EWTX Position: Q2 2026 in Review

State of Wyoming opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 12,913 shares worth $525K. The stake represents 0.05% of the portfolio and ranks #376 among its holdings. This is a return to the name: State of Wyoming previously reported a position in EWTX as recently as Q1 2022.

State of Wyoming first reported a position in EWTX in Q2 2021 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • State of Wyoming held 12,913 shares of Edgewise Therapeutics worth $525K as of Q2 2026.
  • Edgewise Therapeutics was a new State of Wyoming position in Q2 2026.
  • Edgewise Therapeutics made up 0.05% of State of Wyoming's portfolio in Q2 2026, its #376 holding.
  • State of Wyoming first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.